nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—testicular cancer	0.307	0.382	CbGbCtD
L-Carnitine—XDH—Carboplatin—testicular cancer	0.0924	0.115	CbGbCtD
L-Carnitine—MPO—Carboplatin—testicular cancer	0.0924	0.115	CbGbCtD
L-Carnitine—MPO—Cisplatin—testicular cancer	0.079	0.0983	CbGbCtD
L-Carnitine—XDH—Cisplatin—testicular cancer	0.079	0.0983	CbGbCtD
L-Carnitine—SLC22A5—Dactinomycin—testicular cancer	0.0617	0.0768	CbGbCtD
L-Carnitine—XDH—Doxorubicin—testicular cancer	0.0529	0.0659	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—testicular cancer	0.0204	0.0254	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—testicular cancer	0.0188	0.0234	CbGbCtD
L-Carnitine—SLC22A16—gonad—testicular cancer	0.00581	0.0665	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—testicular cancer	0.00542	1	CbGdCrCtD
L-Carnitine—SLC25A20—seminal vesicle—testicular cancer	0.00506	0.0578	CbGeAlD
L-Carnitine—CRAT—seminal vesicle—testicular cancer	0.00491	0.0561	CbGeAlD
L-Carnitine—SLC22A16—testis—testicular cancer	0.00419	0.0479	CbGeAlD
L-Carnitine—CPT2—seminal vesicle—testicular cancer	0.00377	0.0432	CbGeAlD
L-Carnitine—SLC25A29—female gonad—testicular cancer	0.00372	0.0426	CbGeAlD
L-Carnitine—CRAT—gonad—testicular cancer	0.00355	0.0406	CbGeAlD
L-Carnitine—CROT—female gonad—testicular cancer	0.00341	0.039	CbGeAlD
L-Carnitine—SLC25A29—testis—testicular cancer	0.0033	0.0378	CbGeAlD
L-Carnitine—CROT—testis—testicular cancer	0.00303	0.0346	CbGeAlD
L-Carnitine—SLC25A20—female gonad—testicular cancer	0.00297	0.034	CbGeAlD
L-Carnitine—CRAT—female gonad—testicular cancer	0.00288	0.033	CbGeAlD
L-Carnitine—CPT1A—gonad—testicular cancer	0.00287	0.0329	CbGeAlD
L-Carnitine—CPT2—gonad—testicular cancer	0.00273	0.0312	CbGeAlD
L-Carnitine—SLC25A20—testis—testicular cancer	0.00263	0.0301	CbGeAlD
L-Carnitine—CRAT—testis—testicular cancer	0.00256	0.0292	CbGeAlD
L-Carnitine—SLC25A29—lymph node—testicular cancer	0.00239	0.0274	CbGeAlD
L-Carnitine—CPT1A—female gonad—testicular cancer	0.00233	0.0267	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00233	0.192	CbGpPWpGaD
L-Carnitine—CPT2—female gonad—testicular cancer	0.00222	0.0254	CbGeAlD
L-Carnitine—CROT—lymph node—testicular cancer	0.00219	0.0251	CbGeAlD
L-Carnitine—CPT1A—testis—testicular cancer	0.00207	0.0237	CbGeAlD
L-Carnitine—CPT2—testis—testicular cancer	0.00197	0.0225	CbGeAlD
L-Carnitine—SLC25A20—lymph node—testicular cancer	0.00191	0.0218	CbGeAlD
L-Carnitine—CRAT—lymph node—testicular cancer	0.00185	0.0212	CbGeAlD
L-Carnitine—SLC22A4—seminal vesicle—testicular cancer	0.00171	0.0196	CbGeAlD
L-Carnitine—CPT1A—lymph node—testicular cancer	0.0015	0.0172	CbGeAlD
L-Carnitine—CPT2—lymph node—testicular cancer	0.00142	0.0163	CbGeAlD
L-Carnitine—CES1—female gonad—testicular cancer	0.00132	0.0151	CbGeAlD
L-Carnitine—CES1—testis—testicular cancer	0.00117	0.0134	CbGeAlD
L-Carnitine—SLC22A5—seminal vesicle—testicular cancer	0.00113	0.0129	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00106	0.0873	CbGpPWpGaD
L-Carnitine—MPO—testis—testicular cancer	0.000975	0.0112	CbGeAlD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000862	0.0711	CbGpPWpGaD
L-Carnitine—CES1—lymph node—testicular cancer	0.000846	0.00968	CbGeAlD
L-Carnitine—CES1—NRF2 pathway—SLC2A6—testicular cancer	0.00075	0.0618	CbGpPWpGaD
L-Carnitine—MPO—lymph node—testicular cancer	0.000706	0.00808	CbGeAlD
L-Carnitine—SLC22A5—female gonad—testicular cancer	0.000664	0.0076	CbGeAlD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000648	0.0534	CbGpPWpGaD
L-Carnitine—SLC22A4—lymph node—testicular cancer	0.000645	0.00738	CbGeAlD
L-Carnitine—SLC22A5—testis—testicular cancer	0.000589	0.00674	CbGeAlD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000586	0.0483	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000538	0.0443	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—STK11—testicular cancer	0.000442	0.0364	CbGpPWpGaD
L-Carnitine—SLC22A5—lymph node—testicular cancer	0.000427	0.00488	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000413	0.034	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000392	0.0323	CbGpPWpGaD
L-Carnitine—Anaemia—Cisplatin—testicular cancer	0.000297	0.00325	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000296	0.0244	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000294	0.0243	CbGpPWpGaD
L-Carnitine—Vomiting—Chlorambucil—testicular cancer	0.000293	0.0032	CcSEcCtD
L-Carnitine—Anorexia—Ifosfamide—testicular cancer	0.00029	0.00317	CcSEcCtD
L-Carnitine—Decreased appetite—Dactinomycin—testicular cancer	0.000289	0.00316	CcSEcCtD
L-Carnitine—Diarrhoea—Vinblastine—testicular cancer	0.000288	0.00315	CcSEcCtD
L-Carnitine—Dysgeusia—Etoposide—testicular cancer	0.000288	0.00315	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000288	0.0237	CbGpPWpGaD
L-Carnitine—Back pain—Etoposide—testicular cancer	0.000285	0.00311	CcSEcCtD
L-Carnitine—Hypotension—Ifosfamide—testicular cancer	0.000284	0.00311	CcSEcCtD
L-Carnitine—Pain—Dactinomycin—testicular cancer	0.000284	0.0031	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—testicular cancer	0.000283	0.0031	CcSEcCtD
L-Carnitine—Body temperature increased—Bleomycin—testicular cancer	0.000282	0.00308	CcSEcCtD
L-Carnitine—Dizziness—Vinblastine—testicular cancer	0.000279	0.00305	CcSEcCtD
L-Carnitine—Convulsion—Cisplatin—testicular cancer	0.000279	0.00305	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000277	0.00303	CcSEcCtD
L-Carnitine—Myalgia—Cisplatin—testicular cancer	0.000274	0.00299	CcSEcCtD
L-Carnitine—Nausea—Chlorambucil—testicular cancer	0.000273	0.00299	CcSEcCtD
L-Carnitine—Paraesthesia—Ifosfamide—testicular cancer	0.000273	0.00299	CcSEcCtD
L-Carnitine—Anxiety—Cisplatin—testicular cancer	0.000273	0.00298	CcSEcCtD
L-Carnitine—Anaemia—Etoposide—testicular cancer	0.000272	0.00298	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000272	0.00297	CcSEcCtD
L-Carnitine—Dyspnoea—Ifosfamide—testicular cancer	0.000271	0.00297	CcSEcCtD
L-Carnitine—Vomiting—Vinblastine—testicular cancer	0.000268	0.00293	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000266	0.022	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—KITLG—testicular cancer	0.000265	0.0218	CbGpPWpGaD
L-Carnitine—Vertigo—Etoposide—testicular cancer	0.000265	0.00289	CcSEcCtD
L-Carnitine—Decreased appetite—Ifosfamide—testicular cancer	0.000265	0.00289	CcSEcCtD
L-Carnitine—Headache—Vinblastine—testicular cancer	0.000264	0.00289	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000263	0.00287	CcSEcCtD
L-Carnitine—Abdominal pain—Dactinomycin—testicular cancer	0.000263	0.00287	CcSEcCtD
L-Carnitine—Body temperature increased—Dactinomycin—testicular cancer	0.000263	0.00287	CcSEcCtD
L-Carnitine—Hypersensitivity—Bleomycin—testicular cancer	0.000262	0.00287	CcSEcCtD
L-Carnitine—Infection—Cisplatin—testicular cancer	0.000261	0.00285	CcSEcCtD
L-Carnitine—Constipation—Ifosfamide—testicular cancer	0.00026	0.00285	CcSEcCtD
L-Carnitine—Pain—Ifosfamide—testicular cancer	0.00026	0.00285	CcSEcCtD
L-Carnitine—Cough—Etoposide—testicular cancer	0.000257	0.00281	CcSEcCtD
L-Carnitine—Tachycardia—Cisplatin—testicular cancer	0.000256	0.0028	CcSEcCtD
L-Carnitine—Asthenia—Bleomycin—testicular cancer	0.000256	0.00279	CcSEcCtD
L-Carnitine—Convulsion—Etoposide—testicular cancer	0.000255	0.00279	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—testicular cancer	0.000254	0.00278	CcSEcCtD
L-Carnitine—Pruritus—Bleomycin—testicular cancer	0.000252	0.00275	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000252	0.0208	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000252	0.0208	CbGpPWpGaD
L-Carnitine—Chest pain—Etoposide—testicular cancer	0.000251	0.00274	CcSEcCtD
L-Carnitine—Nausea—Vinblastine—testicular cancer	0.00025	0.00274	CcSEcCtD
L-Carnitine—Anorexia—Cisplatin—testicular cancer	0.00025	0.00273	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000249	0.00272	CcSEcCtD
L-Carnitine—Hypotension—Cisplatin—testicular cancer	0.000245	0.00268	CcSEcCtD
L-Carnitine—Hypersensitivity—Dactinomycin—testicular cancer	0.000245	0.00268	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—testicular cancer	0.000243	0.00265	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—testicular cancer	0.000242	0.00264	CcSEcCtD
L-Carnitine—Abdominal pain—Ifosfamide—testicular cancer	0.000241	0.00263	CcSEcCtD
L-Carnitine—Body temperature increased—Ifosfamide—testicular cancer	0.000241	0.00263	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000239	0.00261	CcSEcCtD
L-Carnitine—Infection—Etoposide—testicular cancer	0.000239	0.00261	CcSEcCtD
L-Carnitine—Asthenia—Dactinomycin—testicular cancer	0.000238	0.00261	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—testicular cancer	0.000237	0.00259	CcSEcCtD
L-Carnitine—Paraesthesia—Cisplatin—testicular cancer	0.000236	0.00258	CcSEcCtD
L-Carnitine—Tachycardia—Etoposide—testicular cancer	0.000235	0.00256	CcSEcCtD
L-Carnitine—Dyspnoea—Cisplatin—testicular cancer	0.000234	0.00256	CcSEcCtD
L-Carnitine—Anorexia—Etoposide—testicular cancer	0.000229	0.0025	CcSEcCtD
L-Carnitine—Decreased appetite—Cisplatin—testicular cancer	0.000228	0.00249	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—testicular cancer	0.000228	0.00249	CcSEcCtD
L-Carnitine—Diarrhoea—Dactinomycin—testicular cancer	0.000227	0.00248	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000227	0.00248	CcSEcCtD
L-Carnitine—Vomiting—Bleomycin—testicular cancer	0.000226	0.00248	CcSEcCtD
L-Carnitine—Depression—Methotrexate—testicular cancer	0.000225	0.00246	CcSEcCtD
L-Carnitine—Hypotension—Etoposide—testicular cancer	0.000225	0.00246	CcSEcCtD
L-Carnitine—Rash—Bleomycin—testicular cancer	0.000225	0.00245	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—testicular cancer	0.000224	0.00245	CcSEcCtD
L-Carnitine—Pain—Cisplatin—testicular cancer	0.000224	0.00245	CcSEcCtD
L-Carnitine—Dermatitis—Bleomycin—testicular cancer	0.000224	0.00245	CcSEcCtD
L-Carnitine—Hypersensitivity—Ifosfamide—testicular cancer	0.000224	0.00245	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—testicular cancer	0.000224	0.00245	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—testicular cancer	0.000222	0.00243	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—testicular cancer	0.000219	0.0024	CcSEcCtD
L-Carnitine—Asthenia—Ifosfamide—testicular cancer	0.000218	0.00239	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—testicular cancer	0.000216	0.00236	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—testicular cancer	0.000216	0.00236	CcSEcCtD
L-Carnitine—Pruritus—Ifosfamide—testicular cancer	0.000215	0.00235	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—testicular cancer	0.000214	0.00234	CcSEcCtD
L-Carnitine—Dyspnoea—Etoposide—testicular cancer	0.000214	0.00234	CcSEcCtD
L-Carnitine—Nausea—Bleomycin—testicular cancer	0.000212	0.00231	CcSEcCtD
L-Carnitine—Vomiting—Dactinomycin—testicular cancer	0.000211	0.00231	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—testicular cancer	0.000211	0.0023	CcSEcCtD
L-Carnitine—Rash—Dactinomycin—testicular cancer	0.000209	0.00229	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—testicular cancer	0.000209	0.00228	CcSEcCtD
L-Carnitine—Diarrhoea—Ifosfamide—testicular cancer	0.000208	0.00228	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—testicular cancer	0.000208	0.00227	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000208	0.00227	CcSEcCtD
L-Carnitine—Body temperature increased—Cisplatin—testicular cancer	0.000207	0.00227	CcSEcCtD
L-Carnitine—Pain—Etoposide—testicular cancer	0.000206	0.00225	CcSEcCtD
L-Carnitine—Constipation—Etoposide—testicular cancer	0.000206	0.00225	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—testicular cancer	0.000205	0.00224	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—testicular cancer	0.000204	0.00223	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—testicular cancer	0.000203	0.00222	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000202	0.0167	CbGpPWpGaD
L-Carnitine—Dizziness—Ifosfamide—testicular cancer	0.000201	0.0022	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—testicular cancer	0.000201	0.0022	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—testicular cancer	0.0002	0.00218	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000199	0.0164	CbGpPWpGaD
L-Carnitine—Weight decreased—Doxorubicin—testicular cancer	0.000198	0.00217	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—testicular cancer	0.000198	0.00217	CcSEcCtD
L-Carnitine—Nausea—Dactinomycin—testicular cancer	0.000197	0.00216	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—testicular cancer	0.000197	0.00215	CcSEcCtD
L-Carnitine—Vomiting—Ifosfamide—testicular cancer	0.000194	0.00212	CcSEcCtD
L-Carnitine—Hypersensitivity—Cisplatin—testicular cancer	0.000193	0.00211	CcSEcCtD
L-Carnitine—Renal failure—Doxorubicin—testicular cancer	0.000192	0.0021	CcSEcCtD
L-Carnitine—Rash—Ifosfamide—testicular cancer	0.000192	0.0021	CcSEcCtD
L-Carnitine—Dermatitis—Ifosfamide—testicular cancer	0.000192	0.0021	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—testicular cancer	0.000191	0.00208	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—testicular cancer	0.00019	0.00208	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—testicular cancer	0.00019	0.00208	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—testicular cancer	0.00019	0.00208	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—testicular cancer	0.00019	0.00208	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—testicular cancer	0.00019	0.00207	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—testicular cancer	0.000189	0.00207	CcSEcCtD
L-Carnitine—Asthenia—Cisplatin—testicular cancer	0.000188	0.00206	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—testicular cancer	0.000188	0.00206	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—testicular cancer	0.000187	0.00204	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—testicular cancer	0.000184	0.00201	CcSEcCtD
L-Carnitine—Sinusitis—Doxorubicin—testicular cancer	0.000183	0.002	CcSEcCtD
L-Carnitine—Nausea—Ifosfamide—testicular cancer	0.000181	0.00198	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KIT—testicular cancer	0.000181	0.0149	CbGpPWpGaD
L-Carnitine—Diarrhoea—Cisplatin—testicular cancer	0.00018	0.00196	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—testicular cancer	0.000177	0.00194	CcSEcCtD
L-Carnitine—Hypersensitivity—Etoposide—testicular cancer	0.000177	0.00194	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—testicular cancer	0.000176	0.00193	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—testicular cancer	0.000176	0.00192	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—testicular cancer	0.000175	0.00192	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—testicular cancer	0.000174	0.0019	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—testicular cancer	0.000173	0.00189	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—testicular cancer	0.000173	0.00189	CcSEcCtD
L-Carnitine—Asthenia—Etoposide—testicular cancer	0.000172	0.00189	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—testicular cancer	0.000172	0.00188	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—testicular cancer	0.000171	0.00187	CcSEcCtD
L-Carnitine—Pruritus—Etoposide—testicular cancer	0.00017	0.00186	CcSEcCtD
L-Carnitine—Arrhythmia—Epirubicin—testicular cancer	0.000169	0.00185	CcSEcCtD
L-Carnitine—Vomiting—Cisplatin—testicular cancer	0.000167	0.00182	CcSEcCtD
L-Carnitine—Rash—Cisplatin—testicular cancer	0.000165	0.00181	CcSEcCtD
L-Carnitine—Dermatitis—Cisplatin—testicular cancer	0.000165	0.00181	CcSEcCtD
L-Carnitine—Diarrhoea—Etoposide—testicular cancer	0.000164	0.0018	CcSEcCtD
L-Carnitine—Eye disorder—Doxorubicin—testicular cancer	0.000164	0.00179	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—testicular cancer	0.000163	0.00178	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000162	0.0134	CbGpPWpGaD
L-Carnitine—Dysgeusia—Epirubicin—testicular cancer	0.000162	0.00177	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—testicular cancer	0.00016	0.00175	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—testicular cancer	0.000159	0.00174	CcSEcCtD
L-Carnitine—Dizziness—Etoposide—testicular cancer	0.000159	0.00174	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—testicular cancer	0.000159	0.00174	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—testicular cancer	0.000159	0.00173	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—testicular cancer	0.000157	0.00171	CcSEcCtD
L-Carnitine—Nausea—Cisplatin—testicular cancer	0.000156	0.0017	CcSEcCtD
L-Carnitine—Cough—Methotrexate—testicular cancer	0.000154	0.00168	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—testicular cancer	0.000153	0.00167	CcSEcCtD
L-Carnitine—Vomiting—Etoposide—testicular cancer	0.000153	0.00167	CcSEcCtD
L-Carnitine—Anaemia—Epirubicin—testicular cancer	0.000153	0.00167	CcSEcCtD
L-Carnitine—Rash—Etoposide—testicular cancer	0.000152	0.00166	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—testicular cancer	0.000151	0.00166	CcSEcCtD
L-Carnitine—Headache—Etoposide—testicular cancer	0.000151	0.00165	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—testicular cancer	0.00015	0.00164	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—testicular cancer	0.00015	0.00164	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00015	0.0123	CbGpPWpGaD
L-Carnitine—Dysgeusia—Doxorubicin—testicular cancer	0.00015	0.00164	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—testicular cancer	0.000148	0.00162	CcSEcCtD
L-Carnitine—Back pain—Doxorubicin—testicular cancer	0.000148	0.00162	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—testicular cancer	0.000147	0.00161	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—testicular cancer	0.000146	0.00159	CcSEcCtD
L-Carnitine—Cough—Epirubicin—testicular cancer	0.000144	0.00157	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—testicular cancer	0.000143	0.00156	CcSEcCtD
L-Carnitine—Infection—Methotrexate—testicular cancer	0.000143	0.00156	CcSEcCtD
L-Carnitine—Nausea—Etoposide—testicular cancer	0.000143	0.00156	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—testicular cancer	0.000143	0.00156	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—testicular cancer	0.000141	0.00154	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—testicular cancer	0.000141	0.00154	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—testicular cancer	0.000141	0.00154	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—testicular cancer	0.00014	0.00153	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—testicular cancer	0.000137	0.0015	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—testicular cancer	0.000137	0.0015	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000135	0.0112	CbGpPWpGaD
L-Carnitine—Palpitations—Doxorubicin—testicular cancer	0.000135	0.00148	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—testicular cancer	0.000135	0.00147	CcSEcCtD
L-Carnitine—Infection—Epirubicin—testicular cancer	0.000134	0.00146	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—testicular cancer	0.000133	0.00146	CcSEcCtD
L-Carnitine—Convulsion—Doxorubicin—testicular cancer	0.000132	0.00145	CcSEcCtD
L-Carnitine—CROT—Metabolism—HPGDS—testicular cancer	0.000132	0.0109	CbGpPWpGaD
L-Carnitine—Hypertension—Doxorubicin—testicular cancer	0.000132	0.00144	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—testicular cancer	0.000132	0.00144	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000131	0.00143	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—testicular cancer	0.00013	0.00142	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—testicular cancer	0.00013	0.00142	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—testicular cancer	0.00013	0.00142	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—testicular cancer	0.00013	0.00142	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—testicular cancer	0.000129	0.00141	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—testicular cancer	0.000128	0.0014	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—testicular cancer	0.000128	0.0014	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—testicular cancer	0.000127	0.00139	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—testicular cancer	0.000126	0.00138	CcSEcCtD
L-Carnitine—Decreased appetite—Methotrexate—testicular cancer	0.000125	0.00137	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000124	0.00136	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—testicular cancer	0.000124	0.00135	CcSEcCtD
L-Carnitine—Pain—Methotrexate—testicular cancer	0.000123	0.00135	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000123	0.00134	CcSEcCtD
L-Carnitine—Insomnia—Epirubicin—testicular cancer	0.000122	0.00133	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—testicular cancer	0.000122	0.00133	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—testicular cancer	0.000121	0.00132	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—testicular cancer	0.00012	0.00131	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—testicular cancer	0.000119	0.0013	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—testicular cancer	0.000119	0.0013	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000118	0.00129	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—testicular cancer	0.000117	0.00128	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—testicular cancer	0.000117	0.00127	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000116	0.00127	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—testicular cancer	0.000115	0.00126	CcSEcCtD
L-Carnitine—Pain—Epirubicin—testicular cancer	0.000115	0.00126	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—testicular cancer	0.000114	0.00124	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—testicular cancer	0.000114	0.00124	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000114	0.00124	CcSEcCtD
L-Carnitine—Insomnia—Doxorubicin—testicular cancer	0.000113	0.00123	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000113	0.00927	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—HPGDS—testicular cancer	0.000112	0.00925	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—HPGDS—testicular cancer	0.000112	0.00925	CbGpPWpGaD
L-Carnitine—Paraesthesia—Doxorubicin—testicular cancer	0.000112	0.00122	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—testicular cancer	0.000111	0.00122	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00011	0.0012	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—testicular cancer	0.00011	0.0012	CcSEcCtD
L-Carnitine—Decreased appetite—Doxorubicin—testicular cancer	0.000108	0.00118	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000108	0.00118	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—testicular cancer	0.000107	0.00117	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—testicular cancer	0.000107	0.00117	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—testicular cancer	0.000107	0.00116	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—testicular cancer	0.000107	0.00116	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—testicular cancer	0.000106	0.00116	CcSEcCtD
L-Carnitine—Asthenia—Methotrexate—testicular cancer	0.000103	0.00113	CcSEcCtD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000103	0.00847	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000102	0.00111	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—testicular cancer	0.000102	0.00111	CcSEcCtD
L-Carnitine—Hypersensitivity—Epirubicin—testicular cancer	9.93e-05	0.00109	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—testicular cancer	9.86e-05	0.00108	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—testicular cancer	9.86e-05	0.00108	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—testicular cancer	9.85e-05	0.00108	CcSEcCtD
L-Carnitine—Asthenia—Epirubicin—testicular cancer	9.67e-05	0.00106	CcSEcCtD
L-Carnitine—CROT—Metabolism—STK11—testicular cancer	9.59e-05	0.0079	CbGpPWpGaD
L-Carnitine—Pruritus—Epirubicin—testicular cancer	9.53e-05	0.00104	CcSEcCtD
L-Carnitine—Dizziness—Methotrexate—testicular cancer	9.52e-05	0.00104	CcSEcCtD
L-Carnitine—Diarrhoea—Epirubicin—testicular cancer	9.22e-05	0.00101	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—testicular cancer	9.19e-05	0.001	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—testicular cancer	9.15e-05	0.001	CcSEcCtD
L-Carnitine—Rash—Methotrexate—testicular cancer	9.08e-05	0.000992	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—testicular cancer	9.07e-05	0.000992	CcSEcCtD
L-Carnitine—Headache—Methotrexate—testicular cancer	9.02e-05	0.000986	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—testicular cancer	8.95e-05	0.000978	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—testicular cancer	8.91e-05	0.000974	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—testicular cancer	8.82e-05	0.000964	CcSEcCtD
L-Carnitine—Vomiting—Epirubicin—testicular cancer	8.57e-05	0.000937	CcSEcCtD
L-Carnitine—Nausea—Methotrexate—testicular cancer	8.55e-05	0.000935	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—testicular cancer	8.53e-05	0.000933	CcSEcCtD
L-Carnitine—Rash—Epirubicin—testicular cancer	8.5e-05	0.000929	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—testicular cancer	8.49e-05	0.000928	CcSEcCtD
L-Carnitine—Headache—Epirubicin—testicular cancer	8.44e-05	0.000923	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—testicular cancer	8.24e-05	0.000901	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—STK11—testicular cancer	8.15e-05	0.00672	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—STK11—testicular cancer	8.15e-05	0.00672	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—testicular cancer	8e-05	0.000875	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—testicular cancer	7.93e-05	0.000867	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—testicular cancer	7.86e-05	0.000859	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—testicular cancer	7.85e-05	0.000859	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—testicular cancer	7.81e-05	0.000854	CcSEcCtD
L-Carnitine—Nausea—Doxorubicin—testicular cancer	7.41e-05	0.00081	CcSEcCtD
L-Carnitine—CPT2—Metabolism—HPGDS—testicular cancer	7.23e-05	0.00596	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—STK11—testicular cancer	5.25e-05	0.00433	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—HPGDS—testicular cancer	5.01e-05	0.00413	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.92e-05	0.00323	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—STK11—testicular cancer	3.64e-05	0.003	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—HPGDS—testicular cancer	3.32e-05	0.00274	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—STK11—testicular cancer	2.41e-05	0.00199	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—HPGDS—testicular cancer	1.75e-05	0.00144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STK11—testicular cancer	1.27e-05	0.00105	CbGpPWpGaD
